A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies

NAActive, not recruitingINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2025

Conditions
Physician WorkflowArtificial Intelligence (AI)
Interventions
OTHER

Use Nabla AI Scribe tool provided

"AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.~Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio."

OTHER

Use AI Scribe tool provided by Vendor B

AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.

Trial Locations (1)

90024

UCLA Health System, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT06792890 - A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies | Biotech Hunter | Biotech Hunter